|
1
|
Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT.
|
J Cell Biol
|
2002
|
1.97
|
|
2
|
Ghrelin: a metabolic signal affecting the reproductive system.
|
Cytokine Growth Factor Rev
|
2009
|
1.48
|
|
3
|
Expression of ghrelin and of the GH secretagogue receptor by pancreatic islet cells and related endocrine tumors.
|
J Clin Endocrinol Metab
|
2002
|
1.45
|
|
4
|
Acylated and unacylated ghrelin promote proliferation and inhibit apoptosis of pancreatic beta-cells and human islets: involvement of 3',5'-cyclic adenosine monophosphate/protein kinase A, extracellular signal-regulated kinase 1/2, and phosphatidyl inositol 3-Kinase/Akt signaling.
|
Endocrinology
|
2006
|
1.43
|
|
5
|
Obestatin promotes survival of pancreatic beta-cells and human islets and induces expression of genes involved in the regulation of beta-cell mass and function.
|
Diabetes
|
2007
|
1.22
|
|
6
|
Ghrelin and des-acyl ghrelin promote differentiation and fusion of C2C12 skeletal muscle cells.
|
Mol Biol Cell
|
2007
|
1.19
|
|
7
|
Characterization of a novel peripheral pro-lipolytic mechanism in mice: role of VGF-derived peptide TLQP-21.
|
Biochem J
|
2012
|
1.06
|
|
8
|
Expression of ghrelin and biological activity of specific receptors for ghrelin and des-acyl ghrelin in human prostate neoplasms and related cell lines.
|
Eur J Endocrinol
|
2004
|
1.05
|
|
9
|
Cardiac effects of ghrelin and its endogenous derivatives des-octanoyl ghrelin and des-Gln14-ghrelin.
|
Eur J Pharmacol
|
2003
|
0.98
|
|
10
|
Proliferative and protective effects of growth hormone secretagogues on adult rat hippocampal progenitor cells.
|
Endocrinology
|
2008
|
0.96
|
|
11
|
The antiproliferative effect of synthetic peptidyl GH secretagogues in human CALU-1 lung carcinoma cells.
|
Endocrinology
|
2002
|
0.93
|
|
12
|
Obestatin affords cardioprotection to the ischemic-reperfused isolated rat heart and inhibits apoptosis in cultures of similarly stressed cardiomyocytes.
|
Am J Physiol Heart Circ Physiol
|
2010
|
0.92
|
|
13
|
Des-acyl ghrelin has specific binding sites and different metabolic effects from ghrelin in cardiomyocytes.
|
Endocrinology
|
2010
|
0.88
|
|
14
|
Ghrelin secretion is inhibited by either somatostatin or cortistatin in humans.
|
J Clin Endocrinol Metab
|
2002
|
0.88
|
|
15
|
Unacylated ghrelin and obestatin increase islet cell mass and prevent diabetes in streptozotocin-treated newborn rats.
|
J Mol Endocrinol
|
2010
|
0.88
|
|
16
|
Ghrelin in fetal thyroid and follicular tumors and cell lines: expression and effects on tumor growth.
|
Am J Pathol
|
2003
|
0.87
|
|
17
|
Short ghrelin peptides neither displace ghrelin binding in vitro nor stimulate GH release in vivo.
|
Endocrinology
|
2002
|
0.87
|
|
18
|
New active series of growth hormone secretagogues.
|
J Med Chem
|
2003
|
0.87
|
|
19
|
Obestatin induced recovery of myocardial dysfunction in type 1 diabetic rats: underlying mechanisms.
|
Cardiovasc Diabetol
|
2012
|
0.85
|
|
20
|
The GH-releasing effect of ghrelin, a natural GH secretagogue, is only blunted by the infusion of exogenous somatostatin in humans.
|
Clin Endocrinol (Oxf)
|
2002
|
0.85
|
|
21
|
Ghrelin and the endocrine pancreas.
|
Endocrine
|
2003
|
0.84
|
|
22
|
Ghrelin: much more than a natural growth hormone secretagogue.
|
Isr Med Assoc J
|
2002
|
0.83
|
|
23
|
Endocrine activities of cortistatin-14 and its interaction with GHRH and ghrelin in humans.
|
J Clin Endocrinol Metab
|
2002
|
0.79
|
|
24
|
Ghrelin and synthetic growth hormone secretagogues are cardioactive molecules with identities and differences.
|
Semin Vasc Med
|
2004
|
0.79
|
|
25
|
Ghrelin and prostate cancer.
|
Vitam Horm
|
2008
|
0.79
|
|
26
|
Brain-gut communication: cortistatin, somatostatin and ghrelin.
|
Trends Endocrinol Metab
|
2007
|
0.79
|
|
27
|
Effects of acute hexarelin administration on cardiac performance in patients with coronary artery disease during by-pass surgery.
|
Eur J Pharmacol
|
2002
|
0.77
|
|
28
|
Expression of cortistatin and MrgX2, a specific cortistatin receptor, in human neuroendocrine tissues and related tumours.
|
J Pathol
|
2005
|
0.76
|
|
29
|
Acylated and unacylated ghrelin attenuate isoproterenol-induced lipolysis in isolated rat visceral adipocytes through activation of phosphoinositide 3-kinase γ and phosphodiesterase 3B.
|
Biochim Biophys Acta
|
2011
|
0.76
|
|
30
|
Targeting the ghrelin receptor: orally active GHS and cortistatin analogs.
|
Endocrine
|
2003
|
0.76
|
|
31
|
Ghrelin: endocrine and non-endocrine actions.
|
J Pediatr Endocrinol Metab
|
2002
|
0.76
|